China
Aoyuan Healthy acquires 55% equity in Liantianmei for $101.72m
Aoyuan Healthy acquires 55% equity in Liantianmei for $101.72m
With this acquisition, Aoyuan holds 60% equity interest in the company.
Chinese pharma market to grow 3.2% this year
The Government’s efforts to cut drug spending will create challenges for international drugmakers.
HSBC releases China pharma market outlook for H2
Small cap companies with low valuations could outperform, but leading companies may provide more stable returns.
Sino Biopharma records $1,852m revenue in H1
Earnings per share were 5.2% higher than that of the same period last year.
Lee's Pharma announces H1 results
The group’s revenue is up 3.9% measured QoQ.
Viva Biotech buys 80% share of Langhua Pharma
The company expects to deliver more comprehensive end-to-end services through this acquisition.
China's healthcare spending to reach $49b by 2023
By then, China will account for 23% of the world’s healthcare spending.
Telemedicine is seeing a radical surge in China
Study revealed around 90% are using online medical services with no intention of reverting to offline sources.
Almost 70% of rare disease patients receiving poor medical attention
Funding for testing and treatment, among others, was cited as the reason behind the inefficiencies across Asia-Pacific.
Bigger healthcare spending in the cards for China
The country saw overwhelmed hospitals and disrupted routine services amidst the pandemic.
KPMG's Chris Hardesty gives a diagnosis of healthcare's present and future
He says health literacy has increased dramatically as a result of the global health situation.
China's healthcare firms bag $6.8b worth of deals in 2020 YTD
The sector has gained attention from investors since the pandemic.
Travel restrictions spur online healthcare services in China
Priorly, less than a quarter of the population had used telemedicine.
Chinese cities grab $355m sovereign loan to revamp health infrastructure
This includes enhancing the treatment capacity of medical institutions to deal with epidemics.
Pandemic triggers reforms in China's healthcare
Only 10 community health centres in Wuhan were prepared to admit COVID-19 patients.
InterSystems TrakCare goes live in Amcare Women's and Children's Hospital, Baodao in Beijing despite coronavirus
As China grapples with the spread of COVID-19, many industries have been impacted, but none more so than the medical industry.
China's healthcare spending tipped to grow 12.6% to $926.8b in 2020
The government is expected to account for the majority of the spending.
Most Read
1. IHH Healthcare to expand network in India 2. What lies ahead for the cell and gene therapy market? 3. Global wearable medical device market to grow $143.7b by 2034 4. SMART launches project researching wearable ultrasound system for elderly care 5. Nearly 60% of Hongkongers delay medical care, report findsResource Center
Read Here
Advertise
Sign Up
Awards
Mar
26
Events
Event News
Healthcare Asia Awards 2025 Winner: Lee Ligang Zhang of iKang Healthcare Group
Lee Ligang Zhang of iKang Healthcare Group highlights how AI and precision diagnosis are transforming healthcare delivery today.
